Continuous Glucose Monitoring Finds Sweet Spot Without the Sting

Written by Laurie L. Sullivan on Jan 9, 2018 2:30:00 PM

Glucose Monitor.jpegThe continuous glucose monitoring market, introduced nearly 20 years ago, is presently experiencing strong growth as diabetics, physicians, hospitals and clinics witness the benefits these devices can lend to the management of glucose levels. The market now includes blood glucose monitors, diabetes test strips, insulin durable and patch pumps, glucose sensors, and transmitters and receivers. The global market for continuous glucose monitoring equipment is expected to top $20.6 billion by 2022, according to a new study by BCC Research, at a five-year compound annual growth rate (CAGR) of 10.1%.

Read More

Topics: Life Sciences, Healthcare

Google Spin-Off Jumps Into the Wearable Device Game

Written by Laurie L. Sullivan on Dec 28, 2017 11:45:00 AM

Smartwatch.jpg

Earlier this month, BCC Research hosted an event “Connected Medical Devices: Bridging the Gap Between Wearables and Clinical Applications” in Boston, MA. BCC Research Senior editors Michael Sullivan and Robert G. Hunter discussed the future of wearable medical devices, especially those that link clinical and consumer applications. In her blog post from August 2017, Laurie Sullivan writes about one Google spin-off coming ever closer to “bridging the gap.”

Read More

Topics: Life Sciences, Healthcare

Can Getting A “Young” Blood Transfusion Turn Back Time?

Written by Laurie L. Sullivan on Nov 8, 2017 10:00:00 AM

Blood Transfusion.jpegConditions such as immunodeficiency and bleeding disorders are powerful growth factors of the blood plasma industry. In a recent analysis, BCC Research found that the rising demand for immunoglobulins (more commonly known as antibodies), an integral part of the immune response, is the main driver of the global market for blood plasma products. Product launches and improvements in existing technologies are expected to expand this market from approximately $16.8 billion in 2016 to $23.0 billion by 2021.

Read More

Topics: Life Sciences, Healthcare

Function Follows Form: Trendy Tattoos Are a Cover-up for Vital Work

Written by Laurie L. Sullivan on Oct 31, 2017 2:30:00 PM

diabetes-blood-sugar-diabetic-medicine-46173.jpegThe use of disposable medical sensors is continuously increasing, fueling a multibillion-dollar global industry. BCC Research predicts that this market will expand at a healthy double-digit growth rate worldwide, with the potential to reach $9 billion by 2022. An increase in geriatric populations all over the world will lead to more demand for continuous health monitoring devices for a larger number of diseases pertaining to cardiovascular, audiology and urology systems.

Read More

Topics: Life Sciences, Healthcare

Biomarker Advances Push Rapid Growth in Biologic Imaging Reagents

Written by Laurie L. Sullivan on Oct 20, 2017 12:15:00 PM

Biologic imaging reagents play a fundamental role in today’s medical, pharmaceutical and biotechnology industries. Such reagents are integral to the diagnostics industry, which is the largest market for these products. Driven primarily by advancements in biomarker technology in medical diagnostics, the global market for biologic imaging reagents has the potential to reach $23.9 billion by 2022. In a new study by BCC Research, the industry’s prospects are examined by the main reagent classes: contrast, nuclear (radioactive) and optical.

Read More

Topics: Life Sciences, Healthcare

Global Market for Pain Management to Surpass $50B by 2022

Written by Laurie L. Sullivan on Sep 7, 2017 10:00:00 AM

Pills-Medicine.jpgThe global market for pain management is poised to expand by more than $15 billion in the next five years. Pain management constitutes a diverse market of products and services to alleviate pain, with the potential to attain $52.0 billion annually by 2022. A recent study by BCC Research examines this industry’s prospects for pharmaceuticals and devices. Manufacturers have attempted to create well-rounded and advanced products to give clinicians a wider range of choices for pain management. As regulatory and cost issues reduce hospital stays and increase home care and other forms of long-term care, awareness of the real costs associated with pain management is growing.

Read More

Topics: Life Sciences, Healthcare

Technology Platform Shifts Shape Laboratory-Developed Testing Market

Written by Laurie L. Sullivan on Sep 5, 2017 10:00:00 AM

The market for laboratory-developed tests (LDTs) is evolving as the result of a mix of technological, financial, and regulatory factors. Broad technology platform shifts are underway. Serological and molecular diagnostic tests are becoming less popular as newer genomic and mass spectrophotometry (MS)–based tests are introduced. BCC Research has also observed that large national and regional reference laboratories are performing more LDTs, while smaller or academic laboratories reduce their testing volumes. High capital costs and low rates of reimbursement are hindering the efforts of smaller laboratories to keep pace with their larger counterparts.

Read More

Topics: Life Sciences, Healthcare

Size Matters: Miniature Medical Lasers Allow Early Disease Detection

Written by Laurie L. Sullivan on Aug 2, 2017 10:00:00 AM

Surgical procedures and emerging applications are fueling the industry for medical laser devices. Consequently, this industry will post a compound annual growth rate (CAGR) of 15.3% through 2022, according to a study by BCC Research. Despite economic slowdowns that can affect cosmetic or elective procedures, demand in the United States and Canada is strong, accounting for nearly half of the global market for medical lasers. Europe and the Asia-Pacific region account for roughly 20% of sales. Overall, revenues are expected to reach $11.5 billion in the next five years.

Read More

Topics: Life Sciences, Healthcare

Mobile Health Breaches Barriers to Healthcare

Written by Laurie L. Sullivan on Jun 26, 2017 11:00:00 AM

An estimated 7 million patients have already used some form of digital health program featuring connected devices as part of a care plan, a statistic that is predicted to reach 50 million by 2020. Recent work by BCC Research explores the expanding world of mobile health (mHealth) care plans, apps, and devices in the United States, Europe, and Japan. The mHealth revolution is being driven by cultural differences, Internet of Things technology, and network connectivity, as well as new patient-centered health policy initiatives.

Read More

Topics: Life Sciences, Healthcare

Blood Industry Gets a Transfusion from an Aging Population

Written by Laurie L. Sullivan on Jun 5, 2017 11:00:00 AM

1PHM1199B-blood.jpgEnsuring safety of the blood supply, the demand for plasma-derived therapeutics, and an aging population are factors driving growth in the global blood industry. The annual growth of plasma-derived therapies, used mostly to treat rare disorders, may exceed 10%. Hemophilia, hepatitis, cancer, and kidney failure are among the many conditions that are managed by blood transfusion or by therapy with plasma or plasma-derived products. An aging population suggests that there will be many more patients who need such products in the future. At a compound annual growth rate (CAGR) of 4.9%, BCC Research predicts the value of the global blood industry to increase from $33.5 billion in 2016 to $42.6 billion in 2021.

Read More

Topics: Life Sciences, Healthcare

Recent Posts